Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Sheng-Chun Dang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8878-9007; OpenAlex author ID A5055827093, A5087450211. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 10

  1. G-Protein-Signaling Modulator 2 Expression and Role in a CD133+ Pancreatic Cancer Stem Cell Subset [Retraction]. Co-author DOI 10.2147/ott.s491280↗
  2. Long non-coding RNAs and pancreatic cancer: A multifaceted view. Last author DOI 10.1016/j.biopha.2023.115601↗
  3. M2 macrophage-derived exosomal long noncoding RNA Myt1l promotes lung metastasis of pancreatic cancer cells via the miR-135/Slug axis First author DOI 10.21203/rs.3.rs-3239578/v1↗
  4. Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mecha… First author DOI 10.21037/jgo-21-224↗
  5. Bioinformatic and experimental analyses of key biomarkers in pancreatic cancer. Last author DOI 10.3892/etm.2021.10794↗
  6. G-protein-signaling modulator 2 expression and role in a CD133+ pancreatic cancer stem cell subset. Co-author DOI 10.2147/ott.s187670↗
  7. Secreted protein acidic and rich in cysteine enhances the chemosensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s13277-015-4044-4↗
  8. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells. First author DOI 10.1007/s13277-015-4607-4↗
  9. Up-regulation of UHRF1 by oncogenic Ras promoted the growth, migration, and metastasis of pancreatic cancer cells. Last author DOI 10.1007/s11010-014-2279-9↗
  10. NOV promoted the growth and migration of pancreatic cancer cells. Co-author DOI 10.1007/s13277-013-1418-3↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Wang · 2 shared papers, 2023 · strength 0.65
  2. Min Gu · 2 shared papers, 2019–2024 · strength 0.37
  3. Xintong Zhou · 1 shared paper, 2021 · strength 0.19
  4. Min Gu · 1 shared paper, 2021 · strength 0.19
  5. Xu‐Qing Wang · 3 shared papers, 2015–2016 · strength 0.18
  6. Lei Cui · 2 shared papers, 2016–2019 · strength 0.17
  7. Xingtong Zhou · 1 shared paper, 2021 · strength 0.17
  8. Tianyu Ren · 1 shared paper, 2021 · strength 0.17
  9. Zhengfa Mao · 3 shared papers, 2014–2016 · strength 0.17
  10. Jianxin Zhang · 3 shared papers, 2014–2016 · strength 0.17
  11. Jixiang Chen · 3 shared papers, 2014–2016 · strength 0.17
  12. Lei Cui · 3 shared papers, 2014–2016 · strength 0.17
  13. Jianxin Zhang · 1 shared paper, 2016 · strength 0.06
  14. Xin Fan · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.